Why even tell us and not just actually do it and tell us that is what they are doing. The consistent carrot dangling is why no one believes a damn thing he writes or says because he has yet to actually come through on any of it.
"1. Now they are thinking about spinning out Eltoprazine or ESS as a standalone company since each has 3 indications it could target."
Nowhere does it say AMBS is thinking about spinning it out themselves which is what you stated. Merely stating the could be there own companies or subsidiary under another company.
News 
Market Data 
Discover 
